From professional translators, enterprises, web pages and freely available translation repositories.
ios
sag
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
ios (Ίος)
ios (Ιος)
Last Update: 2014-11-13
Usage Frequency: 1
Quality:
[ninox ios]
[for ninox ios]
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
pazeminot ios, duotrav samazina bojājumu risku.
by lowering the iop, duotrav reduces the risk of damage.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
brimonidīna ios pazeminošā iedarbība varētu būt ilgāka.
the iop-lowering effect of brimonidine may be longer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
timolols pazemina ios, samazinot acs iekšējā šķidruma veidošanos.
timolol lowers iop by reducing aqueous humour formation.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Ārstējot šādus pacientus ir jāievēro piesardzība un rūpīga ios kontrole.
caution should be utilised in treating these patients and close monitoring of iop is recommended.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
esošie dati liecina, ka ievadīšana vakarā sekmē labāku ios samazināšanos.
existing data suggest that evening dosing might have some advantages in the mean iop reduction.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokinētiskā/farmakodinamiskā attiecība cilvēkam attiecībā uz ios pazemināšanu nav noteikta.
the pharmacokinetic/pharmacodynamic relationship in humans for iop- lowering has not been established.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
novērota arī ilgstoša ios paaugstināšanās (skatīt 4.8 apakšpunktu).
sustained iop increases have also been identified (see section 4.8).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
iekļaušanas kritēriji visos pētījumos bija kopīgi, izņemot sākotnējo ios un reakciju uz iepriekšējo terapiju.
inclusion criteria were common across the studies, with the exception of the iop entry criteria and response to previous iop therapy.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
3. tabula: ios izmaiņas (mmhg), salīdzinot izba no bāzes spiediena
table 3: iop change from baseline (mmhg) for izba
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
azarga lieto, lai samazinātu intraokulāro spiedienu (ios, acs iekšējo spiedienu).
azarga is used to reduce intra-ocular pressure (iop, pressure inside the eye).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tika veikti pieci pētījumi, kuros bija iesaistīti 1499 pacienti ar paaugstinātu ios, ko izraisīja atvērtā leņķa glaukoma vai okulārā hipertensija.
five clinical studies were carried out in 1,499 patients with raised iop caused by open-angle glaucoma or ocular hypertension.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
kaut arī simbrinza ios pazeminošās iedarbības ilgums nav pētīts, sagaidāms, ka brinzolamīda ios pazeminošā iedarbība ilgs 5-7 dienas.
while the duration of iop-lowering effect for simbrinza has not been studied, the iop-lowering effect of brinzolamide is expected to last for 5-7 days.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
turklāt, ir izpētīta azopt kā prostaglandīna analoga travoprostu papildinošas terapijas ietekme uz ios (intraokulārā spiediena) samazināšanu.
additionally the iop-reducing effect of azopt as adjunctive therapy to the prostaglandin analogue travoprost has been studied.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daži pacienti nebija nekad saņēmuši intraokulārā spiediena (ios) pazeminošus medikamentus, daži jau lietoja citus ios pazeminošus medicīniskus preparātus.
some patients were naive to iop therapy whilst others were on other iop-lowering medicinal product(s).
Last Update: 2017-04-26
Usage Frequency: 3
Quality: